We are live on ! Find out more
ZIVOW

Zivo Bioscience, Inc. Warrants
ZIVOW

Delisted

ZIVOW was delisted on the 24th of November, 2023.

Back to rankings

5 hedge funds and large institutions have $81K invested in Zivo Bioscience, Inc. Warrants in 2022 Q4 according to their latest regulatory filings, with funds opening new positions, 2 increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 5 → 5 (0)

18% less capital invested

Capital invested by funds: $99K → $81K (-$18K)

Holders
5
Holders Change
–
Holders Change %
0%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
WAM
Warberg Asset Management
Illinois
+$1.29K
2
UBS Group
UBS Group
Switzerland
+$428

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
WAM
1
Warberg Asset Management
Illinois
$41.1K +$1.29K +1,854 +2%
AC
2
Ayrton Capital
Connecticut
$37.6K – – –
CH
3
CVI Holdings
Delaware
$1.13K – – –
VCA
4
Verdence Capital Advisors
Maryland
$701 – – –
UBS Group
5
UBS Group
Switzerland
$417 +$428 +614 +11%

ZIVOW Hedge Fund Activity: Q4 2022 in Review

5 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Zivo Bioscience, Inc. Warrants (ZIVOW) for Q4 2022, worth a combined $81K — down 18% from $99K a quarter earlier.

Fund positioning in ZIVOW was balanced in Q4 2022: 0 funds opened new positions, 0 closed out, 2 added to existing stakes and 0 trimmed.

The largest buyer was Warberg Asset Management, adding an estimated $1.29K.

  • 5 institutional investors held Zivo Bioscience, Inc. Warrants (ZIVOW) as of Q4 2022, unchanged from Q3 2022.
  • Funds reported $81K of Zivo Bioscience, Inc. Warrants stock for Q4 2022, down 18% quarter-over-quarter.
  • 0 funds opened new Zivo Bioscience, Inc. Warrants positions in Q4 2022 and 0 closed out.
  • The largest Zivo Bioscience, Inc. Warrants buyer in Q4 2022 was Warberg Asset Management, an estimated $1.29K added.

Based on aggregated 13F filings for Q4 2022.